Biote Corp.
A maker of bioidentical hormone replacement therapy products, Biote Corp. trains and certifies doctors to implant tiny, grain-of-rice-sized hormone pellets under the skin, and supplies the kits, software, and marketing support their practices need. The company was founded in 2012 by OB/GYN Gary Donovitz, who turned to hormone therapy after seeing it transform a patient's life, and went public in 2022. Its name is a mashup of "bioidentical" and "testosterone."
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time.
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time.
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time.
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 13G/APassive | 1.2% | 359.7K | Jul 27, 2026 |
| Bandera Partners LLC | 13G/APassive | 6.4% | 2.07M | May 13, 2026 |
| Bylinsky Gregory | 13G/APassive | 6.4% | 2.07M | May 13, 2026 |
| Gramm Jefferson | 13G/APassive | 6.4% | 2.07M | May 13, 2026 |
| Roystone Management Holdings LLC | 13DActivist | 14% | 4.62M | Jun 12, 2025 |
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time. | ||||
| RB Management GP LLC | 13DActivist | 14% | 4.62M | Jun 12, 2025 |
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time. | ||||
| Guines LLC | 13DActivist | 14% | 4.62M | Jun 12, 2025 |
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time. | ||||
| Richard Barrera | 13DActivist | 14% | 4.62M | Jun 12, 2025 |
The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions. The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time. | ||||
| Roystone Management Holdings LLC | 13G/APassive | 12% | 3.93M | Mar 18, 2025 |
| RB Management GP LLC | 13G/APassive | 12% | 3.93M | Mar 18, 2025 |